Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
Lucid Diagnostics(LUCD) Prnewswire·2024-07-23 20:01
"Our commercial and clinical teams remain relentlessly focused on expanding awareness of, demand for and access to EsoGuard esophageal precancer testing at physician offices, integrated health systems and #CheckYourFoodTube testing events," said Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer. About Lucid Diagnostics This press release includes forward-looking statements that involve risk and uncertainties. Forward-looking statements are any statements that are not historical facts. Such fo ...